Private equity firm Everstone Capital has signed an agreement to acquire a controlling stake in Calibre, a specialty ingredients manufacturer focused on the pharmaceutical, nutritional and personal care segments, the investor said in a statement on Sunday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
